Capillary electrophoresis-mass spectrometry for glycoscreening in biomedical research.
Application of capillary electrophoresis (CE) in combination with mass spectrometry (MS) and tandem MS to glycoscreening in biomedical projects is highlighted. In the first part recent CE-MS experiments by sheath liquid CE and multiple stage MS are reported. Neutral and negatively charged N-glycan mixtures from ribonuclease B and fetuin, high-mannose type N-glycoforms, oligosaccharides from lipopolysaccharides (LPS) of Haemophilus influenzae, polysaccharides of Pseudomonas aeruginosa and Staphylococcus aureus were analyzed. A particular emphasis is devoted to the applicability of novel off- and on-line CE-MS and tandem MS methods for screening of proteoglycan-derived oligosaccharides, glycosaminoglycans (GAGs), such as hyaluronates from Streptococcus agalactiae, chondroitin/dermatan sulfates (CS/DS) from bovine aorta and human skin fibroblast decorin, and heparin/heparan sulfate (HS) from porcine and bovine mucosa. The performance of CE-MS/MS for identification of glycoforms in glycopeptides and glycoproteins is illustrated by experiments performed on complex mixtures from urine of patients suffering from a hereditary N-acetylhexosaminidase deficiency (Schindler's disease) and urine of patients suffering from cancer cachexia. For determination of glycosylation patterns in glycoproteins like enzymes and antibodies by CE/MS, both CE-matrix assisted laser desorption/ionization (MALDI) and CE-electrospray ionization (ESI)-MS were functional. Finally, the potential of CE-ESI-MS strategy in glycolipid analysis is demonstrated for gangliosides from bovine brain for which particular CE buffer conditions are required.
Zamfir
Alina
A
Institute for Medical Physics and Biophysics, Biomedical Analysis Department, University of Münster, Münster, Germany.
Peter-Katalinić
Jasna
J
Institute for Medical Physics and Biophysics, Biomedical Analysis Department, University of Münster, Münster, Germany.
D000818:Animals; D035843:Biomedical Research / Q000379:methods; D019075:Electrophoresis, Capillary / Q000379:methods* / Q000639:trends; D005732:Gangliosides / Q000032:analysis / Q000737:chemistry; D006020:Glycopeptides / Q000032:analysis / Q000737:chemistry; D006025:Glycosaminoglycans / Q000032:analysis / Q000737:chemistry; D006801:Humans; D008070:Lipopolysaccharides / Q000032:analysis / Q000737:chemistry; D013058:Mass Spectrometry / Q000379:methods* / Q000639:trends; D009844:Oligosaccharides / Q000032:analysis / Q000737:chemistry; D011509:Proteoglycans / Q000032:analysis / Q000737:chemistry
D005732:Gangliosides; D006020:Glycopeptides; D006025:Glycosaminoglycans; D008070:Lipopolysaccharides; D009844:Oligosaccharides; D011509:Proteoglycans